greeksoup/ stock research
Stock research / United States / TRNS · Instruments For Meas & Testing Of Electricity & Elec Signals · Nasdaq

Transcat Inc. (TRNS)

Compare with another name

Transcat Inc. (TRNS) reported revenue of $93 million for Q1 FY2027, the quarter ended 27 June 2026, up 21.6% on the same quarter a year earlier. Net income was $1 million, down 59.2% on the year, and diluted earnings per share $0.14. The figures are the company's own, from the 10-Q it filed with the SEC on 4 August 2026.

Revenue$93 millionup 21.6%
Net income$1 milliondown 59.2%
Diluted EPS$0.14
QuarterQ1 FY2027ended 27 June 2026

Transcat (TRNS) in brief

Transcat (TRNS) reported revenue of $332 million for fiscal 2026, the year ended 28 March 2026, up 19.2% on the year before.
Read moreNet income was $5 million and diluted earnings per share $0.57. Revenue was $278 million in fiscal 2025, $259 million in fiscal 2024, $231 million in fiscal 2023 and $205 million in fiscal 2022. Net income in the same years was $15 million, $14 million, $11 million and $11 million. Revenue grew 13.9% a year, compounded, over the five years to fiscal 2026. Transcat had 9 million shares outstanding at the latest filed count. At 27 June 2026 it carried $110 million of debt and $7 million of cash. At the close of 29 October 2026 the market cap of Transcat was $842 million.

Ratios

From the filings

ROEn/a
ROCEn/a
Operating marginn/a
Net marginn/a
FCF marginn/a
Interest covern/a
Debt to equity0.36
Cash conversionn/a
Share count, last 12 months0.4%
Sales CAGR, 3 years12.9%
Profit CAGR, 3 years-20.5%
EPS, TTMn/a

At the close of 29 October 2026

Price$89.95
Market cap$842 million
Stock P/En/a
Price to book2.78
EV / EBITDAn/a
Dividend yieldn/a
Market cap / salesn/a
52-week high$97.76
52-week low$52.06
Price, 1 year21.1%
Price CAGR, 3 years-1.2%
Price CAGR, 5 years3.7%
Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on long-term debt as Transcat Inc. files it, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.
TRNSgreeksoup.ai
Daily prices to 29 October 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

The public record on TRNS

Dividendsno dividend in its filings for fiscal 2010 onward
Filings16 in twelve months: 8 current reports (8-K), about 4 results of operations; 3 officer or director change; 2 regulation FD disclosure; 1 shareholder vote; 1 material agreement
Planned insider sales2 Form 144 notices in twelve months, $6.9 million; latest 3 September 2026
Options tapeput/call 0.04 by open interest at the 29 October 2026 close; the straddle prices a 11.4% move to 20 November 2026
13F holders172 funds reported a position for the quarter to 30 June 2026; largest Neuberger Berman Group LLC
Insider trading2 sales and 1 purchase on Form 4 in twelve months
Congress0 House trades disclosed in six months
Short interest441,861 shares short, 4.00 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Quarterly results, the last 20 quarters

Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026Q1 FY2027
Revenue47.850.450.955.954.756.457.462.160.662.865.270.966.767.866.877.176.482.383.992.9
Cost of revenue34.335.837.339.238.639.741.042.941.942.744.246.944.146.647.151.250.6n/a58.662.2
Gross profit13.514.613.616.716.016.816.419.118.720.120.924.022.721.219.725.925.8n/a25.330.7
Gross margin28%29%27%30%29%30%29%31%31%32%32%34%34%31%29%34%34%n/a30%33%
Operating income3.73.62.44.53.63.63.25.94.61.64.39.25.13.72.16.95.3n/a0.13.7
Operating margin8%7%5%8%7%6%6%9%8%3%7%13%8%6%3%9%7%n/a0%4%
Interest expensen/an/an/an/an/an/a0.7n/a0.80.90.10.10.10.10.20.50.5n/a1.51.5
Pre-tax income3.53.32.24.13.43.12.14.83.80.84.39.65.23.73.16.34.6n/a-1.42.2
Tax rate-6%9%27%26%11%24%25%24%22%43%22%28%16%12%25%29%29%n/an/a39%
Net income3.73.01.63.03.12.41.63.72.90.53.36.94.43.32.44.53.3n/a-1.11.3
Net margin8%6%3%5%6%4%3%6%5%1%5%10%7%5%4%6%4%n/a-1%1%
Diluted EPS$0.49$0.40$0.21$0.40$0.40$0.31$0.21$0.48$0.38$0.06$0.38$0.77$0.48$0.35$0.25$0.48$0.35n/a-$0.12$0.14
Operating cash flow2.15.44.95.22.03.28.73.07.58.410.95.78.96.812.610.63.6n/a12.18.8
Capital expenditure1.22.62.14.32.42.42.42.32.82.73.74.23.74.02.92.74.6n/a2.74.0
Free cash flow0.92.92.80.9-0.40.86.40.74.85.87.31.55.22.99.77.9-1.0n/a9.54.8
Buybacks3.42.30.01.00.40.00.00.00.31.90.02.71.61.40.20.40.0n/a-0.01.9
Shares outstanding7m8m8m8m8m8m8m8m8m8m9m9m9m9m9m9m9m9m9m9m
Filing10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss), 17 fiscal years

FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue81.191.2110112119124122144155161173173205231259278332
Cost of revenue61.867.955.154.553.456.893.0109118122131127147162176189224
Gross profit19.323.327.127.429.829.129.135.037.439.342.546.158.468.483.889.5108
Gross margin23.8%25.5%24.7%24.4%25.1%23.5%23.8%24.3%24.1%24.5%24.5%26.6%28.5%29.6%32.3%32.1%32.6%
Operating income2.44.65.45.96.76.86.37.99.010.210.811.114.116.219.817.913.3
Operating margin2.9%5.0%4.9%5.3%5.7%5.5%5.2%5.5%5.8%6.4%6.3%6.4%6.9%7.0%7.6%6.4%4.0%
Interest expense0.10.10.1n/an/an/an/an/an/an/an/an/a0.82.41.80.84.6
Pre-tax income2.34.55.25.76.46.46.07.27.99.29.710.013.213.518.418.38.0
Income tax0.81.71.92.02.52.41.92.62.02.11.72.21.82.84.83.82.6
Effective tax rate36.4%37.8%37.1%35.2%38.2%37.3%31.3%36.9%25.5%22.6%17.1%21.9%13.7%20.8%26.0%20.8%32.7%
Net income1.52.83.33.74.04.04.14.55.97.18.17.811.410.713.614.55.4
Net margin1.8%3.1%3.0%3.3%3.4%3.3%3.4%3.1%3.8%4.4%4.7%4.5%5.6%4.6%5.3%5.2%1.6%
Diluted EPS$0.19$0.37$0.43$0.49$0.54$0.57$0.58$0.64$0.81$0.95$1.08$1.03$1.50$1.40$1.63$1.57$0.57
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. FY2026: the four quarters as first filed in the 10-Qs do not add to the year as filed in the 10-K, because the company later restated them (a spin-off or discontinued operations).

Revenue by segment FY2024 to FY2026

FY2024FY2025FY2026Share
of the parts, latest year
Service Segment17018121765.4%
Distribution Segment90.097.011534.6%
Service SegmentDistribution Segment
259FY2024278FY2025332FY2026

$ million; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Profit by segment FY2024 to FY2026

The operating profit each segment reports. Costs Transcat does not charge to a segment are left out, so the segments can add up to more than the company's own operating profit.

FY2024FY2025FY2026Margin
FY2026
Service Segment15.015.24.92.3%
Distribution Segment4.72.78.37.3%
Service SegmentDistribution Segment
19.8FY202417.9FY202513.3FY2026

$ million; the figure over a bar is all the segments together. Hover a block for its profit, sales and margin.

FY2026Share of salesShare of profit
Service Segment65%37%
Distribution Segment35%63%

Each column adds to 100%. A segment with a bigger share of the profit than of the sales makes more on each dollar it sells.

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where every segment with sales that year has an operating profit figure. A margin is a segment's operating profit over its own sales.

Revenue by product or service FY2024 to FY2026

FY2024FY2025FY2026Share
of the parts, latest year
Service17018121765.4%
Distribution Service90.097.011534.6%
ServiceDistribution Service
259FY2024278FY2025332FY2026

$ million; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Revenue by region FY2024 to FY2026

FY2024FY2025FY2026Share
of the parts, latest year
United States23525631093.4%
Canada16.717.217.35.2%
Other International7.75.44.71.4%
United StatesCanadaOther International
259FY2024278FY2025332FY2026

$ million; hover a block for its figure and share

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Cash flow and capital returned

FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow5.62.66.35.27.64.411.07.59.912.611.623.617.617.032.639.034.9
Capital expenditure1.11.61.42.72.03.54.15.25.97.06.66.610.29.413.313.215.3
Free cash flow4.50.94.92.65.70.96.92.34.05.65.017.07.57.519.325.819.6
Free cash flow margin5.6%1.0%4.4%2.3%4.8%0.8%5.6%1.6%2.6%3.5%2.9%9.8%3.6%3.3%7.5%9.3%5.9%
Cash from investing-4.1-5.1-4.5-9.7-1.7-10.7n/a-12.2-5.9-10.9-20.2-10.2-39.9-18.5-41.7-84.0-97.8
Cash from financing-1.52.4-1.84.8-6.65.0n/a4.8-4.0-1.78.2-12.723.70.927.426.966.5
Depreciation and amortisation2.12.32.92.72.93.13.96.26.06.46.77.69.611.013.518.626.2
Share-based compensation0.60.40.60.30.50.50.40.51.41.30.91.52.33.44.53.27.5
Buybacks0.60.60.20.16.50.10.10.10.40.12.83.06.70.44.93.60.5
Diluted shares, weighted8m8m8m8m7m7m7m7m7m8m7m8m8m8m8m9m9m
Shares outstanding at period endn/a7m7m7m7m7m7m7m7m7m7m7m8m8m9m9m9m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet at year end

FY2010FY2011FY2012FY2013FY2014FY2015FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Funded by
Shareholders' equity20.323.327.431.630.134.338.943.451.359.667.175.186.299.6225287301
Debtn/a5.33.48.07.612.219.127.322.921.030.319.648.549.14.232.799.9
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/a6.88.09.213.014.921.429.0
Other liabilitiesn/a12.814.215.416.215.718.721.422.624.623.929.533.934.043.444.351.0
Total liabilities and equityn/a41.445.055.053.962.176.792.196.8105128132178196288385480
Owned
Fixed assetsn/a5.35.36.97.19.412.315.617.119.720.822.226.429.138.950.057.8
Goodwilln/a11.713.417.617.420.929.132.532.734.541.543.365.169.4106177218
Intangible assetsn/a2.02.43.72.73.68.27.55.55.28.07.514.713.820.054.877.7
Investmentsn/an/an/an/an/an/an/an/an/an/an/an/an/a0.015.50.0n/a
Cash and equivalents0.10.00.00.40.00.10.60.80.60.80.50.61.41.519.61.54.9
Receivablesn/a12.113.815.415.716.917.122.024.727.531.034.039.744.747.855.965.2
Inventoryn/a7.66.46.86.26.86.510.312.714.314.211.612.716.917.414.513.7
Other assetsn/a2.83.64.34.94.62.83.33.63.212.113.017.720.422.731.643.0
Total assetsn/a41.445.055.053.962.176.792.196.8105128132178196288385480
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded10.5%13.9%12.9%20.5%
Profit growth, compounded2.7%-7.2%-20.5%n/a
Return on equity, average9.3%7.4%4.3%1.8%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was Transcat's revenue in fiscal 2026?

Transcat (TRNS) reported revenue of $332 million for fiscal 2026, the year ended 28 March 2026, up 19.2% on the year before.

How much did Transcat earn in fiscal 2026?

Net income was $5 million for fiscal 2026, and diluted earnings per share $0.57.

What is Transcat's market cap?

The market cap of Transcat was $842 million at the close of 29 October 2026.

How much debt does Transcat have?

At 27 June 2026 Transcat carried $110 million of debt and $7 million of cash.

Peers: Measuring and Control Equipment

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
Teradyne, Inc. TER$46.3 billion40.6433.5%30.2%57.9%0.000.2%
Veralto Corp. VLTO$25.4 billion26.2631.9%22.7%6.2%1.090.5%
Itron, Inc. ITRI$4.1 billion15.2916.5%13.7%-3.6%0.95n/a
Cohu Inc. COHU$2.7 billionn/a-2.9%-2.4%34.0%0.38n/a
Aehr Test Systems AEHR$2.0 billionn/a-3.2%-28.3%-15.2%0.00n/a
Allient Inc. ALNT$1.6 billion53.969.2%8.4%10.6%0.560.1%
Pacific Biosciences of California, Inc. PACB$904 millionn/an/a-83.5%2.0%n/a0.0%
Transcat Inc. TRNS$842 millionn/an/an/an/a0.36n/a
Cytek Biosciences, Inc. CTKB$818 millionn/a-25.0%-21.6%5.4%0.00n/a
Frequency Electronics Inc. FEIM$787 million287.222.2%2.5%6.3%0.00n/a
Mesa Laboratories Inc. MLAB$744 million158.292.5%9.0%3.0%0.760.5%
908 Devices Inc. MASS$489 millionn/an/an/an/a0.00n/a
All 40 in Measuring and Control Equipment
CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
Thermo Fisher Scientific Inc. TMO$262.3 billion38.1513.2%17.6%7.2%0.810.3%
KLA Corp. KLAC$218.5 billion41.9280.6%n/a15.8%0.880.5%
Danaher Corp. DHR$166.7 billion38.788.1%20.4%5.5%0.490.6%
Trane Technologies plc TT$94.4 billion30.4534.6%17.9%10.3%0.461.2%
AMETEK Inc. AME$57.7 billion36.8014.0%25.9%12.7%0.18n/a
Keysight Technologies, Inc. KEYS$56.2 billion45.3319.2%20.3%25.5%0.38n/a
Agilent Technologies, Inc. A$51.1 billion35.6819.6%22.2%8.6%0.540.6%
Rockwell Automation, Inc. ROK$50.1 billion42.3234.4%22.7%11.3%0.931.2%
Waters Corp. WAT$47.1 billion119.701.1%7.1%52.5%0.33n/a
Coherent Corp. COHR$46.5 billion57.727.4%11.9%22.5%0.30n/a
Teradyne, Inc. TER$46.3 billion40.6433.5%30.2%57.9%0.000.2%
Roper Technologies Inc. ROP$44.5 billion18.6313.4%28.0%10.9%0.610.8%
Illumina, Inc. ILMN$43.7 billion54.0429.1%19.7%4.9%0.70n/a
Mettler Toledo International Inc. MTD$37.3 billion38.687,062.4%n/a6.9%164.70n/a
Veralto Corp. VLTO$25.4 billion26.2631.9%22.7%6.2%1.090.5%
Fortive Corp. FTV$19.6 billion31.3511.0%19.6%7.0%0.59n/a
Revvity, Inc. RVTY$18.5 billion78.913.3%12.3%4.1%0.450.2%
Trimble Inc. TRMB$15.2 billionn/a-2.0%17.0%5.8%0.29n/a
MKS Inc. MKSI$14.6 billion34.4714.7%15.7%16.3%1.320.4%
Avantor, Inc. AVTR$11.3 billion33.355.8%7.3%0.9%0.63n/a
Onto Innovation Inc. ONTO$10.9 billion83.406.9%12.0%8.1%0.00n/a
10x Genomics, Inc. TXG$10.4 billionn/a-9.1%-14.3%-4.3%0.00n/a
Bio-Rad Laboratories, Inc. BIO$10.3 billion46.563.1%2.1%1.4%0.17n/a
Cognex Corp. CGNX$9.9 billion57.2610.7%21.9%17.1%0.000.6%
Bruker Corp. BRKR$9.4 billionn/a-3.0%-0.9%1.6%0.76n/a
Ralliant Corp. RAL$7.8 billionn/a-80.4%-53.3%n/a0.750.1%
Sensata Technologies Holding plc ST$6.0 billion16.5312.0%15.1%4.1%0.78n/a
Vontier Corp. VNT$4.9 billion14.8929.2%18.8%0.9%1.590.3%
Badger Meter Inc. BMI$4.3 billion34.6119.4%18.8%-2.2%0.001.1%
Itron, Inc. ITRI$4.1 billion15.2916.5%13.7%-3.6%0.95n/a
Cohu Inc. COHU$2.7 billionn/a-2.9%-2.4%34.0%0.38n/a
Aehr Test Systems AEHR$2.0 billionn/a-3.2%-28.3%-15.2%0.00n/a
Allient Inc. ALNT$1.6 billion53.969.2%8.4%10.6%0.560.1%
Pacific Biosciences of California, Inc. PACB$904 millionn/an/a-83.5%2.0%n/a0.0%
Transcat Inc. TRNS$842 millionn/an/an/an/a0.36n/a
Cytek Biosciences, Inc. CTKB$818 millionn/a-25.0%-21.6%5.4%0.00n/a
Frequency Electronics Inc. FEIM$787 million287.222.2%2.5%6.3%0.00n/a
Mesa Laboratories Inc. MLAB$744 million158.292.5%9.0%3.0%0.760.5%
908 Devices Inc. MASS$489 millionn/an/an/an/a0.00n/a
Mirion Technologies, Inc. MIR$350 million160.521.6%6.0%19.6%0.67n/a
7 companies share its SEC industry code (Instruments For Meas & Testing Of Electricity & Elec Signals); the rest are the names nearest in size in its wider industry, Measuring and Control Equipment, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

Filings

FilingPeriodFiledWhere
10-Q27 June 20264 August 2026EDGAR
10-K28 March 202627 May 2026EDGAR
10-Q27 December 20253 February 2026EDGAR
10-Q27 September 20255 November 2025EDGAR
10-Q28 June 20256 August 2025EDGAR
10-K29 March 202527 May 2025EDGAR
10-Q28 December 20245 February 2025EDGAR
10-Q28 September 20246 November 2024EDGAR
10-Q29 June 20247 August 2024EDGAR
10-K30 March 202428 May 2024EDGAR